Pharmachem Exports (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 30-03-2024
- Paid Up Capital ₹ 0.10 M
as on 30-03-2024
- Company Age 28 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2020)
- Profit 52.83%
(FY 2020)
- Ebitda 58.68%
(FY 2020)
- Net Worth -15.70%
(FY 2020)
- Total Assets -13.49%
(FY 2020)
About Pharmachem Exports (India)
- CIN/LLPIN
U51397MH1996PTC101366
- Company No.
101366
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 1996
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmachem Exports (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paras Gundecha  | Director | 25-Jul-1996 | Current |
| Deepak Gundecha | Director | 15-Dec-2006 | Current |
Financial Performance of Pharmachem Exports (India).
Pharmachem Exports (India) Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 52.83% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmachem Exports (India)?
In 2017, Pharmachem Exports (India) had a promoter holding of 100.00%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Waves Hotels And Estates Pvt LtdActive 40 years 6 monthsParas Gundecha and Deepak Gundecha are mutual person
Rockline Developers Private LimitedActive 35 years 3 monthsParas Gundecha and Deepak Gundecha are mutual person
Neha Home Builders Private LimitedActive 16 years 10 monthsParas Gundecha and Deepak Gundecha are mutual person
Kashtamandup Developers Private LimitedActive 14 years 8 monthsParas Gundecha and Deepak Gundecha are mutual person
Gundecha Properties Pvt LtdActive 42 years 5 monthsParas Gundecha and Deepak Gundecha are mutual person
Gundecha Estates Private LimitedActive 42 years 5 monthsParas Gundecha and Deepak Gundecha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmachem Exports (India)?
Unlock and access historical data on people associated with Pharmachem Exports (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmachem Exports (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmachem Exports (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
